List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 2013-17
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: Global pharmaceuticals market share: % share, by value, 2017
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the global pharmaceuticals market, 2017
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2017
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2017
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2017
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2017
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2017
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2013-17
Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2017
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2017-22
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2017
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2017
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2017
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2017
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2017
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2017
Figure 21: Europe pharmaceuticals market value: $ billion, 2013-17
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 23: Europe pharmaceuticals market share: % share, by value, 2017
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2017-22
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2017
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2017
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2017
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2017
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2017
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2017
Figure 31: France pharmaceuticals market value: $ billion, 2013-17
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 33: France pharmaceuticals market share: % share, by value, 2017
Figure 34: France pharmaceuticals market value forecast: $ billion, 2017-22
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2017
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2017
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2017
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2017
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2017
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2017
Figure 41: Germany pharmaceuticals market value: $ billion, 2013-17
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 43: Germany pharmaceuticals market share: % share, by value, 2017
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2017-22
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2017
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2017
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2017
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2017
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2017
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2017
Figure 51: Australia pharmaceuticals market value: $ billion, 2013-17
Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 53: Australia pharmaceuticals market share: % share, by value, 2017
Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2017-22
Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2017
Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2017
Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2017
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2017
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2017
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2017
Figure 61: Brazil pharmaceuticals market value: $ billion, 2013-17
Figure 62: Brazil pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 63: Brazil pharmaceuticals market share: % share, by value, 2017
Figure 64: Brazil pharmaceuticals market value forecast: $ billion, 2017-22
Figure 65: Forces driving competition in the pharmaceuticals market in Brazil, 2017
